ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,643.01
      0.49%
      US Tech 100
      19,938.00
      0.73%
      Dow Jones
      40,301.00
      0.75%
      Brent Oil
      84.35
      -0.29%
      Bitcoin
      63,151.48
      3.90%
      Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NYSE
      6. AbbVie Inc (ABBV)

      7. AbbVie Inc (ABBV) News

      ABBV

      AbbVie (ABBV)

      AbbVie Inc
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NYSE:ABBV
      DateTimeSourceHeadlineSymbolCompany
      11/06/20204:30PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NYSE:ABBVAbbVie Inc
      11/05/20209:00AMPR Newswire (US)AbbVie to Highlight Blood Cancer Leadership and Advancing Oncology Pipeline at the ASH 62ND Annual MeetingNYSE:ABBVAbbVie Inc
      11/04/202011:35AMDow Jones NewsAbbVie Up Over 9%, On Pace for Largest Percent Increase Since January 2018 -- Data TalkNYSE:ABBVAbbVie Inc
      11/04/20209:54AMEdgar (US Regulatory)Quarterly Report (10-q)NYSE:ABBVAbbVie Inc
      10/30/202010:05AMDow Jones NewsCorrection to AbbVie Earnings ArticleNYSE:ABBVAbbVie Inc
      10/30/20208:37AMDow Jones NewsAbbVie Logs 3Q Sales Growth on Higher Immunology, Oncology ResultsNYSE:ABBVAbbVie Inc
      10/30/20207:53AMEdgar (US Regulatory)Current Report Filing (8-k)NYSE:ABBVAbbVie Inc
      10/30/20207:47AMPR Newswire (US)AbbVie Reports Third-Quarter 2020 Financial ResultsNYSE:ABBVAbbVie Inc
      10/29/20202:05AMPR Newswire (US)AbbVie to Present New Analyses from Pivotal Phase 3 Studies for RINVOQ™ (upadacitinib) in Atopic DermatitisNYSE:ABBVAbbVie Inc
      10/28/20209:06AMDow Jones NewsAllergan Presbyopia Treatment Hits Main Endpoint in Phase 3 StudiesNYSE:ABBVAbbVie Inc
      10/28/20208:31AMPR Newswire (US)AbbVie Highlights Innovative Research for People with Rheumatic Diseases with New Data at ACR Convergence 2020NYSE:ABBVAbbVie Inc
      10/28/20208:00AMPR Newswire (US)Allergan, an AbbVie Company, Announces Positive Phase 3 Topline Results for Investigational AGN-190584 for the Treatment of P...NYSE:ABBVAbbVie Inc
      10/20/20208:45AMInvestorWireBanking on the Next Blockbuster DrugNYSE:ABBVAbbVie Inc
      10/19/202010:53AMDow Jones NewsAbbVie Seeks U.S., European OK of Rinvoq in EczemaNYSE:ABBVAbbVie Inc
      10/19/202010:06AMPR Newswire (US)AbbVie Submits Regulatory Applications to FDA and EMA for RINVOQ™ (upadacitinib) in Atopic DermatitisNYSE:ABBVAbbVie Inc
      10/19/20209:14AMEdgar (US Regulatory)Current Report Filing (8-k)NYSE:ABBVAbbVie Inc
      10/19/20208:56AMPR Newswire (US)AbbVie Announces Commencement of Registered Exchange OffersNYSE:ABBVAbbVie Inc
      10/19/20208:01AMEdgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)NYSE:ABBVAbbVie Inc
      10/19/20206:04AMEdgar (US Regulatory)Notice of Effectiveness (effect)NYSE:ABBVAbbVie Inc
      10/16/20207:34PMPR Newswire (US)VENCLEXTA® (venetoclax) Receives FDA Full Approval for Acute Myeloid Leukemia (AML)NYSE:ABBVAbbVie Inc
      10/16/20207:59AMDow Jones NewsNIH to Study Three Drugs in Treatment of Covid-19 PatientsNYSE:ABBVAbbVie Inc
      10/09/20209:00AMPR Newswire (US)Allergan Aesthetics To Present Data From 4 Abstracts At The 2020 American Society For Dermatologic Surgery Virtual MeetingNYSE:ABBVAbbVie Inc
      10/07/202010:33AMDow Jones NewsAbbVie's Allergan to Buy Luminera Dermal-Filler BusinessNYSE:ABBVAbbVie Inc
      10/07/20208:00AMPR Newswire (US)Allergan Aesthetics, an AbbVie Company, Acquires Innovative Luminera Dermal Filler BusinessNYSE:ABBVAbbVie Inc
      10/06/20208:00AMPR Newswire (US)AbbVie to Host Third-Quarter 2020 Earnings Conference CallNYSE:ABBVAbbVie Inc
      10/02/20204:55PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NYSE:ABBVAbbVie Inc
      10/02/20204:54PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NYSE:ABBVAbbVie Inc
      10/02/20204:54PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NYSE:ABBVAbbVie Inc
      10/02/20204:06PMEdgar (US Regulatory)Current Report Filing (8-k)NYSE:ABBVAbbVie Inc
      10/02/20208:30AMPR Newswire (US)AbbVie to Present New Data From 15 Abstracts at the 2020 Virtual Migraine Trust International SymposiumNYSE:ABBVAbbVie Inc
       Showing the most relevant articles for your search:NYSE:ABBV